Double-blind, placebo-controlled study of Alternaria alternata immunotherapy: Clinical efficacy and safety

Pediatric Allergy and Immunology ◽

10.1111/j.1399-3038.2007.00589.x ◽

2007 ◽

Vol 0 (0) ◽

pp. 070725210739001-??? ◽

Author(s):

Ana I. Tabar ◽

María T. Lizaso ◽

Blanca E. García ◽

Belen Gómez ◽

Susana Echechipía ◽

...

Keyword(s):

Clinical Efficacy ◽

Alternaria Alternata ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Clinical efficacy and safety of preseasonal sublingual immunotherapy with grass pollen carbamylated allergoid in rhinitic patients. A double-blind, placebo-controlled study

Allergologia et Immunopathologia ◽

10.1157/13094026 ◽

2006 ◽

Vol 34 (5) ◽

pp. 194-198 ◽

Author(s):

A.G. Palma-Carlos ◽

A.S. Santos ◽

M. Branco-Ferreira ◽

A.L. Pregal ◽

M.L. Palma-Carlos ◽

...

Keyword(s):

Clinical Efficacy ◽

Grass Pollen ◽

Sublingual Immunotherapy ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Clinical efficacy and safety of topiroxostat in Japanese male hyperuricemic patients with or without gout: an exploratory, phase 2a, multicentre, randomized, double‐blind, placebo‐controlled study

Journal of Clinical Pharmacy and Therapeutics ◽

10.1111/jcpt.12392 ◽

2016 ◽

Vol 41 (3) ◽

pp. 298-305 ◽

Author(s):

T. Hosoya ◽

T. Sasaki ◽

H. Hashimoto ◽

R. Sakamoto ◽

T. Ohashi

Keyword(s):

Clinical Efficacy ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Download Full-text

Mo1540 THE EFFICACY AND SAFETY OF GCWB104 (FLOS LONICERA EXTRACT) IN FUNCTIONAL DYSPEPSIA: A SINGLE-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY

Gastroenterology ◽

10.1016/s0016-5085(20)32906-1 ◽

2020 ◽

Vol 158 (6) ◽

pp. S-887-S-888

Author(s):

Nayoung Kim ◽

Yonghoon Choi ◽

Dong Ho Lee

Keyword(s):

Functional Dyspepsia ◽

Controlled Study ◽

Efficacy And Safety ◽

Single Center ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Protocol for a prospective, randomised, double-blind, placebo-controlled study to assess the clinical efficacy of crenotherapy with sulfurous thermal waters in patients with chronic rhinitis / rhinosinusitis

Boletin Sociedad Española Hidrologia Medica ◽

10.23853/bsehm.2018.0667 ◽

2018 ◽

Vol 33 (S1) ◽

pp. 188-189

Author(s):

A Esteves ◽

J Viegas ◽

R Pastorinho ◽

O Lourenco ◽

AM Fonseca ◽

...

Keyword(s):

Clinical Efficacy ◽

Controlled Study ◽

Thermal Waters ◽

Double Blind ◽

Double Blind Placebo ◽

Chronic Rhinitis

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725732407.793547378 ◽

2018 ◽

Author(s):

Maria Laura Bertolaccini

Keyword(s):

Systemic Lupus Erythematosus ◽

Monoclonal Antibody ◽

Lupus Erythematosus ◽

Phase Iii ◽

Controlled Study ◽

Efficacy And Safety ◽

Systemic Lupus ◽

Double Blind ◽

Double Blind Placebo ◽

B Cell Activating Factor

Download Full-text

Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of AS-013, a Prostaglandin E1Prodrug, in Patients With Intermittent Claudication

Circulation ◽

10.1161/01.cir.95.9.2298 ◽

1997 ◽

Vol 95 (9) ◽

pp. 2298-2302 ◽

Author(s):

J.J.F. Belch ◽

P.R.F. Bell ◽

D. Creissen ◽

J.A. Dormandy ◽

R.C. Kester ◽

...

Keyword(s):

Intermittent Claudication ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Statement of Retraction: Efficacy and safety of vortioxetine for the treatment of major depressive disorder: a randomised double-blind placebo-controlled study

International Journal of Psychiatry in Clinical Practice ◽

10.1080/13651501.2021.1950437 ◽

2021 ◽

pp. 1-1

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Controlled Study ◽

Efficacy And Safety ◽

Major Depressive ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

The efficacy and safety of dupilumab in Chinese patients with moderate‐to‐severe atopic dermatitis: a randomized, double‐blind, placebo‐controlled study

British Journal of Dermatology ◽

10.1111/bjd.20690 ◽

2021 ◽

Author(s):

Y. Zhao ◽

L. Wu ◽

Q. Lu ◽

X. Gao ◽

X. Zhu ◽

...

Keyword(s):

Atopic Dermatitis ◽

Chinese Patients ◽

Controlled Study ◽

Severe Atopic Dermatitis ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Treatment With Sirukumab (CNTO 136) in Patients With Active Lupus Nephritis

Arthritis & Rheumatology ◽

10.1002/art.39722 ◽

2016 ◽

Vol 68 (9) ◽

pp. 2174-2183 ◽

Author(s):

Brad H. Rovin ◽

Ronald F. van Vollenhoven ◽

Cynthia Aranow ◽

Carrie Wagner ◽

Robert Gordon ◽

...

Keyword(s):

Lupus Nephritis ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Active Lupus Nephritis ◽

Download Full-text

Randomised clinical trial: a multicentre, double-blind, placebo-controlled study on the efficacy and safety of rabeprazole 5 mg or 10 mg once daily in patients with non-erosive reflux disease

Alimentary Pharmacology & Therapeutics ◽

10.1111/j.1365-2036.2010.04508.x ◽

2010 ◽

Vol 33 (2) ◽

pp. 213-224 ◽

Author(s):

Y. Kinoshita ◽

K. Ashida ◽

M. Hongo ◽

Keyword(s):

Clinical Trial ◽

Reflux Disease ◽

Randomised Clinical Trial ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text